EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for FEMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -1.331
March 31, 2026 0.0842
December 31, 2025 -1.326
September 30, 2025 -2.045
June 30, 2025 -3.176
March 31, 2025 -0.2345
December 31, 2024 -4.495
September 30, 2024 -0.2433
June 30, 2024 -0.2109
March 31, 2024 -0.1653
December 31, 2023 -0.2036
September 30, 2023 -0.2648
June 30, 2023 -0.2208
Date Value
March 31, 2023 -0.2482
December 31, 2022 -0.2452
September 30, 2022 -0.2525
June 30, 2022 -0.223
March 31, 2022 -0.2442
December 31, 2021 -0.2003
September 30, 2021 -0.1915
June 30, 2021 -0.0918
March 31, 2021 -0.1505
December 31, 2020 -0.1411
September 30, 2020 -0.1333
June 30, 2020 -0.1259
March 31, 2020 -0.1811

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5324
AngioDynamics, Inc. -0.2735
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832
Baxter International, Inc. 0.2432